tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Nanalysis Reports Q3 2025 Revenue Decline Amid Global Trade Uncertainty

Story Highlights
  • Nanalysis Scientific focuses on portable NMR and MRI technologies for industrial and research use.
  • The company saw a 12% revenue drop in Q3 2025 due to reduced third-party sales and trade issues.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Nanalysis Reports Q3 2025 Revenue Decline Amid Global Trade Uncertainty

TipRanks Black Friday Sale

An announcement from Nanalysis Scientific ( (TSE:NSCI) ) is now available.

Nanalysis Scientific Corp. reported a 12% decrease in consolidated revenue for the third quarter of 2025 compared to the same period in 2024, primarily due to reduced third-party equipment sales and global trade uncertainties. Despite challenges in product sales, the company saw a 10% increase in security services revenue, attributed to enhanced project work in the Airport Security Maintenance Business. The company is phasing out third-party sales to focus on its core products, expecting improved margins as supply chain issues are resolved.

More about Nanalysis Scientific

Nanalysis Scientific Corp. is a leader in the development of portable NMR spectrometers and MRI technology, catering to industrial and research applications. The company is focused on advancing its Benchtop NMR products and magnetic resonance platform, while also improving its service business.

YTD Price Performance: -44.62%

Average Trading Volume: 117,690

Technical Sentiment Signal: Sell

Current Market Cap: C$20.84M

Find detailed analytics on NSCI stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1